Understanding NF1: Basics and Diagnosis

Receiving a diagnosis of Neurofibromatosis Type 1 (NF1) for yourself or your child can feel overwhelming, but understanding the condition is the first step in managing it effectively. NF1 is a genetic condition that affects how cells grow and communicate ^[1]. It is a common “rare” disorder, occurring in approximately 1 in 2,500 to 1 in 4,000 births worldwide ^[1][2].

The Biological Cause of NF1

NF1 is caused by a change (mutation) in the NF1 gene, located on chromosome 17 ^[3]. This gene is responsible for producing a protein called neurofibromin ^[4].

In a body without NF1, neurofibromin acts like a “brake” on cell growth ^[4]. It regulates the Ras/MAPK pathway, a signaling track that tells cells when to divide and grow ^[5]. When the NF1 gene is mutated, the body doesn’t produce enough working neurofibromin, and the “brake” fails ^[6]. This leads to an overactive Ras/MAPK pathway, causing cells to grow more than they should, which can result in the tumors and other features associated with the condition ^[7][8].

Inheritance and “De Novo” Mutations

NF1 is autosomal dominant, meaning a person only needs one copy of the mutated gene to have the condition ^[3].

• In about 50% of cases, the condition is inherited from a parent who also has NF1 ^[1].
• In the other 50%, it occurs as a de novo mutation—a spontaneous change in the gene that happens for the first time in that individual, with no family history of the disorder ^[1][9].

Updated Diagnostic Criteria (2021)

For decades, doctors used criteria established in 1988. However, in 2021, international experts revised these rules to include modern technology and improve early diagnosis ^[10]. A diagnosis of NF1 is confirmed if a person meets two or more of the following:

1. Six or more café-au-lait macules: Flat, light-brown birthmarks (often called “coffee with milk” spots). To count toward a diagnosis, these spots must be at least 5 millimeters (mm) across in children before puberty, and at least 15 mm across in teens and adults ^[11].
2. Two or more neurofibromas (bumps on or under the skin) or one plexiform neurofibroma (a larger, more complex nerve tumor) ^[11].
3. Freckling in the armpits or groin area ^[11].
4. Optic pathway glioma: A tumor on the nerve that connects the eye to the brain ^[11].
5. Two or more Lisch nodules (tiny bumps on the colored part of the eye) OR two or more choroidal abnormalities ^[10][12].
6. Distinctive bone lesions, such as thinning of the shin bone (tibial dysplasia) ^[11].
7. A pathogenic NF1 variant: A confirmed mutation in the NF1 gene found through genetic testing ^[10].
8. A parent with NF1 based on the criteria above ^[11].

Key Changes in the 2021 Criteria

The 2021 update introduced two major changes that help children get diagnosed earlier:

• Genetic Testing: The identification of a mutation in the NF1 gene is now a formal diagnostic tool ^[10]. Previously, the diagnosis was purely based on physical signs, which can take years to appear in young children.
• Choroidal Abnormalities: These are small, painless spots in the back of the eye that do not affect vision. They can be seen using near-infrared reflectance (NIR) imaging ^[12][13]. These spots often appear earlier than Lisch nodules, allowing for a faster diagnosis ^[14][10].

Why Early Diagnosis Matters

NF1 is highly variable; even members of the same family can have very different symptoms ^[15]. While there is currently no universal way to predict exactly how the condition will progress for an individual, an early diagnosis allows for proactive monitoring ^[10]. Regular check-ups with specialists can help identify and manage potential complications—such as vision changes or learning needs—at the earliest possible stage, ensuring you or your child receives the best possible support.